HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptides, and their canonical binding mode involves anchor residues at the second and last positions of their ligands. To investigate potential noncanonical binding modes, we collected in-depth and accurate HLA peptidomics datasets covering 54 HLA-I alleles and developed algorithms to analyze these data. Our results reveal frequent (442 unique peptides) and statistically significant C-terminal extensions for at least eight alleles, including the common HLA-A03:01, HLA-A31:01, and HLA-A68:01. High resolution crystal structure of HLA-A68:01 with such a ligand uncovers structural changes taking place to accommodate C-terminal extensions and helps unra...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup>...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
Published in final edited form as: Nat Biotechnol. 2020 February ; 38(2): 199–209. doi:10.1038/s4158...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
Antigen presentation lies at the heart of immune recognition of infected or malignant cells. For thi...
Antigen presentation lies at the heart of immune recognition of infected or malignant cells. For thi...
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a reperto...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup>...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptid...
<div><p>The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
The precise identification of Human Leukocyte Antigen class I (HLA-I) binding motifs plays a central...
Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have l...
MHC class I molecules (HLA-I in humans) present peptides derived from endogenous proteins to CTLs. W...
Published in final edited form as: Nat Biotechnol. 2020 February ; 38(2): 199–209. doi:10.1038/s4158...
The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central ro...
Antigen presentation lies at the heart of immune recognition of infected or malignant cells. For thi...
Antigen presentation lies at the heart of immune recognition of infected or malignant cells. For thi...
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a reperto...
Ag presentation on HLA molecules plays a central role in infectious diseases and tumor immunology. T...
Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acid...
HLA-I molecules bind short peptides and present them for recognition by CD8 <sup>+</sup>...